Literature DB >> 15681710

Reduction of heart rate by chronic beta1-adrenoceptor blockade promotes growth of arterioles and preserves coronary perfusion reserve in postinfarcted heart.

Eduard I Dedkov1, Lance P Christensen, Robert M Weiss, Robert J Tomanek.   

Abstract

Adequate growth of coronary vasculature in the remaining left ventricular (LV) myocardium after myocardial infarction (post-MI) is a crucial factor for myocyte survival and performance. We previously demonstrated that post-MI coronary angiogenesis can be stimulated by bradycardia induced with the ATP-sensitive K(+) channel antagonist alinidine. In this study, we tested the hypothesis that heart rate reduction with beta-blockade may also induce coronary growth in the post-MI heart. Transmural MI was induced in 12-mo-old male Sprague-Dawley rats by occlusion of the left anterior descending coronary artery. Bradycardia was induced by administration of the beta-adrenoceptor blocker atenolol (AT) via drinking water (30 mg/day). Three groups of rats were compared: 1) control/sham (C/SH), 2) MI, and 3) MI + AT. In the MI + AT rats, heart rate was consistently reduced by 25-28% compared with C/SH rats. At 4 wk after left anterior descending coronary ligation, infarct size was similar in MI and MI + AT rats (67.1 and 61.5%, respectively), whereas a greater ventricular hypertrophy occurred in bradycardic rats, as indicated by a higher ventricular weight-to-body weight ratio (3.4 +/- 0.1 vs. 2.8 +/- 0.1 mg/g in MI rats). Analysis of LV function revealed a smaller drop in ejection fraction in the MI + AT than in the MI group ( approximately 24 vs. approximately 35%). Furthermore, in MI + AT rats, maximal coronary conductance and coronary perfusion reserve were significantly improved compared with the MI group. The better myocardial perfusion indexes in MI + AT rats were associated with a greater increase in arteriolar length density than in the MI group. Thus chronic reduction of heart rate induced with beta-selective blockade promotes growth of coronary arterioles and, thereby, facilitates regional myocardial perfusion in post-MI hearts.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681710     DOI: 10.1152/ajpheart.01047.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  6 in total

1.  Temporally expressed PDGF and FGF-2 regulate embryonic coronary artery formation and growth.

Authors:  Robert J Tomanek; Heidi K Hansen; Lance P Christensen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-17       Impact factor: 8.311

2.  Divergent effects of losartan and metoprolol on cardiac remodeling, c-kit+ cells, proliferation and apoptosis in the left ventricle after myocardial infarction.

Authors:  Raisa Serpi; Anna-Maria Tolonen; Olli Tenhunen; Oskari Pieviläinen; Anna-Maria Kubin; Tommi Vaskivuo; Ylermi Soini; Risto Kerkelä; Hanna Leskinen; Heikki Ruskoaho
Journal:  Clin Transl Sci       Date:  2009-12       Impact factor: 4.689

3.  Structural composition of myocardial infarction scar in middle-aged male and female rats: does sex matter?

Authors:  Yevgen Bogatyryov; Robert J Tomanek; Eduard I Dedkov
Journal:  J Histochem Cytochem       Date:  2013-07-18       Impact factor: 2.479

4.  Coronary vessels and cardiac myocytes of middle-aged rats demonstrate regional sex-specific adaptation in response to postmyocardial infarction remodeling.

Authors:  Eduard I Dedkov; Kunal Oak; Lance P Christensen; Robert J Tomanek
Journal:  Biol Sex Differ       Date:  2014-01-03       Impact factor: 5.027

Review 5.  New advances in beta-blocker therapy in heart failure.

Authors:  Vincenzo Barrese; Maurizio Taglialatela
Journal:  Front Physiol       Date:  2013-11-14       Impact factor: 4.566

6.  Sex-related differences in intrinsic myocardial properties influence cardiac function in middle-aged rats during infarction-induced left ventricular remodeling.

Authors:  Eduard I Dedkov; Yevgen Bogatyryov; Kristina Pavliak; Adora T Santos; Yue-Feng Chen; Youhua Zhang; Alessandro Pingitore
Journal:  Physiol Rep       Date:  2016-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.